查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1853956

Johne氏病诊断市场按动物类型、检测类型、最终用户、通路和技术划分－2025-2032年全球预测

Johne's Disease Diagnostics Market by Animal Type, Test Type, End User, Distribution Channel, Technology - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，Johne氏病诊断市场将成长至 13.5453 亿美元，复合年增长率为 13.99%。

关键市场统计数据
基准年 2024 4.7487亿美元
预计年份：2025年 5.4216亿美元
预测年份 2032 1,354,530,000 美元
复合年增长率 (%) 13.99%

Johne氏病诊断的概要概述重点介绍了当前挑战、新兴技术和动物健康领域领导者的策略重点。

Johne氏病已成为一项持续且复杂的动物健康管理挑战，诊断的准确性和及时性对于有效的防治策略至关重要。本概要概述了相关现状，并将诊断需求置于动物健康计画和研究重点的框架内。它重点阐述了生物学、农场实践和实验室能力之间的相互作用，这些因素共同决定了检测结果和后续的管理选择。

为了将认知转化为行动，相关人员需要明确诊断方法、各自的表现特征，以及如何根据牛类型和生产目标选择合适的检测方法。分子和免疫学方法的进步带来了新的机会，但它们与传统方法并存，后者在临床阶段和操作限制下仍然适用。因此，必须制定诊断流程，并充分考虑动物种类、检体物流以及采样和结果解读的实际操作。

从战术性侦测转向战略监测需要一个能够协调实验室能力、终端使用者需求和技术应用的通用框架。本导言概述了这样一个框架，组装诊断考虑视为更广泛的疾病缓解、生物安全通讯协定和价值链韧性的重要投入。此外，本导言也强调了实证决策的必要性，即在科学严谨性与实地部署和商业性畜牧养殖的实际情况之间取得平衡。

分子技术的进步、整合的资料工作流程和先进的牛管理策略正在改变Johne氏病的诊断方式。

由于技术创新、数据驱动的决策流程以及生产者和医疗保健专业人员不断变化的期望，Johne氏病的诊断格局正在改变。分子扩增技术和即时检测平台缩短了检测週期，提高了感染早期阶段的灵敏度。同时，免疫检测的改进提高了特异性，并扩大了血清学筛检在牛管理方案中的应用范围。

同时，数位化整合和实验室资讯管理系统正在促进诊断服务提供者和农民之间更顺畅的资料流。这些整合的工作流程支援趋势分析、风险分层和针对性检测策略，在减少不必要采样的同时，提高了诊断实用资讯的产量。此外，兽医诊所、研究机构和诊断实验室之间的跨部门合作正在推动检验研究和真实世界证据的生成，从而加速最佳实践的推广应用。

随着这些转变的生效，营运模式也在改变。农场采样通讯协定、低温运输物流和远端咨询服务都在不断发展，以支援先进检测技术的广泛应用。技术成熟和营运创新相结合，使得精准监测在整个生产系统中更容易实现，前提是相关人员能够解决成本、培训和监管协调方面的障碍。

分析美国关税对Johne氏病诊断的影响，重点在于供应链韧性、试剂进口和采购调整

美国政策导致的近期关税调整对诊断相关产品的采购和分销动态产生了显着影响。诊断平台、试剂和专用耗材通常在生产和分销的多个环节跨境运输。关税增加了进口设备和一次性试剂的到岸成本，这可能会加重采购预算压力，并延缓向下一代检测技术的升级。

这些与贸易相关的压力也会波及整个供应链，促使在地采购，但也限制了企业取得集中在少数全球供应商手中的专用试剂。因此，实验室和诊所面临暂时的产能限制、更长的前置作业时间以及供应商多元化的需求。为此，许多医疗机构正在重新审视库存政策、协商长期合约并评估套件替代策略，以维持诊断服务的连续性。

除了对成本和供应的直接影响外，关税变化也加速了围绕供应链韧性和策略采购的讨论。相关人员正在评估替代分销模式、区域合作和本地生产等应对措施。因此，政策制定者和行业领导者应考虑采取协调一致的应对措施，在贸易政策目标与兽医诊断的实际操作之间取得平衡，以确保持续获得​​有效疾病控制所需的工具。

针对Johne氏病诊断，从动物种类、检测方法、最终用户、分销管道和技术等方面进行细分，可以获得相关洞察，从而指导策略制定。

细緻的细分方法能够清楚展现诊断需求、技术需求和服务提供的融合，为产品开发和市场拓展提供实际的指导。在考虑牲畜类型时，检测策略应区分牛和小反刍动物。牛的分析应进一步区分肉牛和乳牛，由于生产相关的经济因素，乳牛群通常需要更频繁的监测；而小反刍动物的策略则应区分绵羊和山羊，因为它们的管理和采样方式有所不同。同时，免疫检测方法，例如包括竞争性ELISA、间接ELISA和夹心ELISA在内的ELISA方法，可提供可扩展的筛检能力；而包括常规PCR和即时PCR在内的PCR方法，则可提供分子层面的确认和定量分析。

终端使用者细分突显了诊断实验室、农场、研究机构和兽医院的不同需求和决策框架。诊断实验室包括医院实验室和独立实验室，每家实验室的处理能力和认证要求各不相同。农场包括育种场和酪农，它们的检测频率和生物安全措施也各不相同。兽医院的规模从独立诊所到提供综合服务的大型诊所不等，而研究机构则倾向于专注于检测方法检验和纵向研究。分销通路细分突显了直销、分销商合作和线上采购的机会，分销商根据规模和覆盖范围分为全国性或区域性。最后，技术细分突出了基于DNA的方法，例如LAMP、PCR和qPCR；免疫检测方法，例如琼脂凝胶免疫扩散和ELISA；以及涵盖液体和固体培养基平台的微生物培养方法。

综合分析这些细分维度，可以实现精准的产品定位和量身订製的商业策略。例如，快速分子检测适用于需要确诊检测的诊断实验室和大型诊所，而可扩展的ELISA检测方法则满足酪农和育种场的大规模筛检需求。了解动物类型、检测特性、终端使用者能力、分销管道和实行技术之间的相互作用，有助于相关人员确定投资优先顺序并制定差异化的价值提案。

Johne氏病诊断在美洲、欧洲、中东和非洲以及亚太地区的区域概览：重点关注监管、供应和应用。

区域背景至关重要，因为不同地区的法规环境、生产系统和供应链架构差异显着。在美洲，诊断技术的普及应用受到一体化供应链、大型酪农和肉牛养殖企业以及完善的实验室网路的影响，这为高通量免疫检测和先进的分子检测提供了契机，从而支持牛层面的监测和商业性风险管理。相较之下，欧洲、中东和非洲的管理体制和兽医基础设施较为分散，因此，统一标准和跨境合作对于提高可靠诊断技术的可近性以及支援区域倡议计画至关重要。

亚太地区涵盖了从小农户到集约化商业农场的多样化生产体系，在对可追溯性和生产效率日益增长的需求驱动下，即时检测和分子检测技术正在迅速普及。在所有三个区域，低温运输可靠性、试剂进口路线以及认证实验室的地理分布等物流因素都会影响哪些诊断方案切实可行。此外，监管核准时间、实验室认证流程以及报销和补贴框架等方面的区域差异也会影响新检测方法的实用化速度。

综合各区域的洞察，成功的商业策略必须使技术部署与当地的监管预期、分销实际情况和最终用户能力相匹配。因此，相关人员需要根据美洲、中东和非洲以及亚太地区各市场的独特特征，量身订做产品设计、服务模式和互动方式，以最大限度地提高市场接受度和营运效率。

对塑造Johne氏病诊断竞争格局的策略定位、伙伴关係、产品系列和研发重点进行竞争分析

Johne氏病诊断领域的企业级动态受产品系列、策略伙伴关係关係以及对实际检验的重视等因素共同影响。领先企业优先考虑将侦测效能与服务等级协定、培训和资料管理工具结合的整合解决方案。诊断试剂生产商、分销网络和兽医服务供应商之间的策略伙伴关係，既能扩大市场覆盖范围，又能保障品质和供应的连续性。

研发投入仍是实现差异化的关键，各公司致力于提高灵敏度和特异性、缩短检测时间，并设计能够在各种检体类型和感染阶段均表现稳定的检测方法。同时，竞争优势往往取决于提供可扩展的解决方案，从适用于人群筛检的高通量ELISA平台到专分散式检查设计的紧凑型分子系统。商业策略也反映出对生命週期支援的日益重视，包括为终端用户提供技术培训、结构化的验证程序以及上市后效能监测。

优先考虑监管合规、供应链韧性和以客户为中心的服务交付的企业倡议更有可能获得持续推广。因此，市场领导将是那些将技术创新与切实可行的上市时间模式相结合的企业，从而使兽医专业人员和生产者能够将诊断资讯转化为及时有效的干预措施。

为产业领导者提供切实可行的建议，以促进诊断技术的普及应用、供应链的韧性、相关人员的协作以及技术选择。

产业领导者可以采取一系列切实可行的措施，加速Johne氏病诊断技术在生产系统中的应用和推广。首先，透过让产品开发蓝图与终端使用者的工作流程保持一致，并与兽医诊所、诊断实验室和农场管理者共同设计检测方法和通讯协定，确保其实用性和使用者接受度。其次，透过多元化采购、与区域分销商合作以及製定策略性库存政策来增强供应链韧性，从而降低贸易中断和试剂短缺的风险。第三，增加训练和技术支援投入，以提高现场侦测的有效性能，减少使用者操作失误，并缩短先进分子侦测方法的学习曲线。

此外，领导者应优先考虑资料互通性，采用标准化的报告格式和实验室资讯系统，以实现及时的资料共用和趋势分析。这将增强监测能力，并支持循证干预措施。与研究机构的合作将加速独立检验，并促进产生支持更广泛应用的真实世界证据。最后，相关人员应积极与监管机构沟通，简化核准途径，并明确新兴诊断方法的绩效预期。实施这些建议将有助于各组织提高诊断方法的可近性，提升监测质量，并提高疾病控制计画的整体有效性。

详细的调查方法，包括一级和二级研究方法、资料检验程序、相关人员参与和分析框架。

本次高阶主管分析的调查方法融合了定性和定量方法，以确保研究的严谨性和有效性。主要研究工作包括对实验室主任、兽医、供应链经理和科研人员进行结构化访谈，以了解其营运实务、检验预期和采购决策标准。除与这些相关人员进行访谈外，在条件允许的情况下，我们还进行了现场考察和流程观察，以深入了解采样物流、产能限制和最终用户培训需求。

二次研究包括对同行评审文献、技术白皮书和监管指南进行系统性回顾，以确定性能声明与技术趋势之间的相关性。我们实施了资料检验通讯协定，将供应商规格与独立的检验研究和现场效能报告进行交叉比对。分析架构采用因果关係图和决策树分析，将技术属性转换为对最终使用者类型和地理环境的实际影响。

「在整个研究设计过程中，我们强调了假设的透明度和可重复性。对于存在不确定性的情况，调查方法侧重于证据权重和敏感性分析，以区分已充分证实的发现和需要进一步检验的领域。这种方法确保了所提出的研究结果稳健可靠、具有可操作性，并能满足参与Johne氏病的决策者的需求。」

结论 我们综合了诊断进展、营运挑战和策略路径，以减少Johne氏病对整个兽医保健系统的影响。

本结论全面分析了Johne氏病消除工作中诊断技术的进步、操作上的挑战以及策略路径。分子检测和纯化免疫检测技术的进步为早期发现感染和製定更精细的牛干预措施提供了重要机会。然而，包括供应链限制、终端用户能力差异以及监管复杂性在内的操作障碍，阻碍了诊断技术的改进转化为疾病影响的显着降低。

弥合这一差距需要各方共同努力。技术提供者必须使产品设计与最终用户的实际工作流程相符，分销网络必须努力提高韧性和响应速度，监管相关人员必须通力合作，明确既能鼓励严格检验又不至于设置过多障碍的途径。同时，对培训和数据基础设施的投资将促进诊断技术的有效应用，并使相关人员能够将检测结果转化为及时的业务决策。

归根结底，实现持续改进的关键在于将科学创新与务实的营运规划相结合。透过优先考虑互通性、循证检验和相关人员协作，该行业可以加强诊断在减轻疾病负担和支持更具韧性的动物健康体系方面的作用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在酪农牛实施农场快速PCR检测，以早期发现Johne氏病
  • 整合次世代定序平台，对牛中Johne氏病株进行全面分析
  • 采用多重ELISA检测平台区分Johne氏病感染及交叉反应性结核分枝桿菌
  • 开发用于Johne氏病临床前诊断和畜群管理的 miRNA 和蛋白质生物标记组合
  • 人工智慧驱动的预测分析技术在农场管理软体的应用，能够预测Johne氏病的爆发。
  • 在全球范围内，监管协调和不断完善的检验通讯协定正在塑造Johne氏病诊断准确性的要求。
  • 提供远端样本分析和Johne氏病即时监测的订阅式诊断服务正在成长。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依动物类型分類的Johne氏病诊断市场

  • 牛
    • 肉牛
    • 乳牛
  • 绵羊和山羊
    • 山羊
    • 羊

第九章Johne氏病诊断市场（依检测类型划分）

  • 文化
    • 液体培养基培养
    • 固体培养基培养
  • ELISA
    • 竞争性ELISA
    • 间接ELISA
    • 夹心ELISA
  • PCR
    • 常规PCR
    • 即时PCR

第十章Johne氏病诊断市场（依最终用户划分）

  • 诊断实验室
    • 医院检查室
    • 独立实验室
  • 农场
    • 养殖场
    • 酪农
  • 研究所
  • 兽医诊所
    • 独立诊所
    • 大型诊所

第十一章Johne氏病诊断市场（依通路划分）

  • 直销
  • 经销商
    • 全国经销商
    • 区域经销商
  • 在线的

第十二章Johne氏病诊断市场（依技术划分）

  • 基于DNA的
    • LAMP
    • PCR
    • qPCR
  • 免疫检测
    • 琼脂凝胶免疫扩散
    • ELISA
  • 微生物培养
    • 液体介质
    • 固态介质

第十三章Johne氏病诊断市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章Johne氏病诊断市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国Johne氏病诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • IDEXX Laboratories, Inc.
    • Zoetis Inc.
    • Thermo Fisher Scientific Inc.
    • Neogen Corporation
    • Abaxis, Inc.
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories, Inc.
    • QIAGEN NV
    • Biocontrol Systems, LLC
    • SeQuent Scientific Limited
Product Code: MRR-0D217D5AD843

The Johne's Disease Diagnostics Market is projected to grow by USD 1,354.53 million at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 474.87 million
Estimated Year [2025] USD 542.16 million
Forecast Year [2032] USD 1,354.53 million
CAGR (%) 13.99%

Executive overview of Johne's disease diagnostics highlighting current challenges, emerging technologies, and strategic priorities for animal health leaders

Johne's disease has emerged as a persistent and complex challenge for livestock health management, with diagnostic fidelity and timeliness at the center of effective control strategies. This executive introduction sets the scene by contextualizing diagnostic needs within herd health initiatives and research priorities. It emphasizes the intersection of biology, farm-level practices, and laboratory capabilities that together determine detection outcomes and downstream management choices.

To move from recognition to action, stakeholders require clarity about diagnostic modalities, their respective performance characteristics, and how test selection interfaces with herd type and production objectives. Advances in molecular and immunological methods have introduced new opportunities, yet they coexist with legacy approaches that retain relevance depending on clinical stage and operational constraints. Consequently, diagnostic pathways must be defined with attention to animal type, specimen logistics, and the practicalities of sampling and result interpretation.

Transitioning from tactical testing to strategic surveillance demands a common framework that aligns laboratory capacity, end-user needs, and technology adoption. This introduction outlines that framework, framing diagnostic considerations as essential inputs to broader disease mitigation, biosecurity protocols, and value-chain resilience. It also underlines the need for evidence-based decision-making that harmonizes scientific rigor with the realities of field deployment and commercial animal production.

Transformative shifts reshaping Johne's disease diagnostics driven by molecular advances, integrated data workflows, and progressive herd management

The diagnostics landscape for Johne's disease is being transformed by convergence of technological innovation, data-enabled decision processes, and evolving expectations from producers and health professionals. Molecular amplification techniques and real-time detection platforms have compressed turnaround times and enhanced sensitivity in earlier stages of infection, thereby enabling interventions that were previously constrained by diagnostic latency. At the same time, improvements in immunoassay formats have refined specificity and broadened the practical utility of serological screening in herd management programs.

Concurrently, digital integration and laboratory information management systems are enabling more coherent data flows between diagnostic providers and farm operators. These integrated workflows support trend analysis, risk stratification, and targeted testing strategies that reduce unnecessary sampling while increasing the yield of diagnostically actionable information. Moreover, cross-sector collaboration between veterinary clinics, research institutions, and diagnostic laboratories is fostering validation studies and real-world evidence generation that accelerate adoption of best practices.

As these shifts take effect, operational models are also changing. On-farm sampling protocols, cold chain logistics, and remote consultation services are evolving to support broader accessibility of advanced tests. The combined effect of technological maturation and operational innovation is to make precision surveillance more attainable across production systems, provided that stakeholders address barriers related to cost, training, and regulatory harmonization.

Impact analysis of United States tariff actions on Johne's disease diagnostics, focusing on supply chain resilience, reagent imports, and procurement adjustments

Recent tariff adjustments originating from United States policy have exerted a discernible influence on the procurement and distribution dynamics of diagnostics-related goods. Diagnostic platforms, reagents, and specialty consumables commonly cross international borders during multiple stages of production and distribution. Tariff measures increase the landed cost of imported instruments and single-use reagents, which in turn exerts pressure on procurement budgets and can delay upgrades to next-generation assays.

These trade-related pressures also reverberate across supply chains, incentivizing localized sourcing but potentially limiting access to specialized reagents that remain concentrated among a limited set of global suppliers. Consequently, laboratories and clinics may face temporary capacity constraints, longer lead times, and a need to diversify suppliers. In response, many organizations are revisiting inventory policies, negotiating longer-term contracts, and evaluating kit substitution strategies to preserve continuity of diagnostic services.

Beyond immediate cost and availability effects, tariff changes have accelerated conversations about supply chain resilience and strategic sourcing. Stakeholders are increasingly evaluating alternative distribution models, regional partnerships, and localized manufacturing as mitigants. Policymakers and industry leaders should therefore consider coordinated responses that balance trade policy objectives with the operational realities of veterinary diagnostics to ensure sustained access to the tools necessary for effective disease control.

Segmentation insights for Johne's disease diagnostics across animal types, test methods, end users, distribution channels, and technologies to inform strategy

A nuanced segmentation approach clarifies where diagnostic demand, technical needs, and service delivery converge, offering actionable guidance for product development and market engagement. When considering animal type, testing strategies must differentiate between cattle and small ruminants; cattle analysis further distinguishes beef cattle and dairy cattle, with dairy herds often requiring more frequent surveillance due to production-linked economic drivers, while small ruminant strategies divide into sheep and goats with distinct management and sampling profiles. Test type segmentation likewise informs operational trade-offs: culture methods retain value for definitive microbial confirmation and are practiced in liquid media culture and solid media culture variants, whereas immunoassays such as ELISA-available in competitive ELISA, indirect ELISA, and sandwich ELISA formats-offer scalable screening capabilities, and PCR modalities including conventional PCR and real-time PCR deliver molecular confirmation and quantitative insights.

End-user segmentation underscores the differing needs and decision frameworks of diagnostic labs, farms, research institutes, and veterinary clinics. Diagnostic labs include hospital labs and independent labs, each with specific throughput and accreditation considerations; farms encompass breeding farms and dairy farms that vary in testing frequency and biosecurity practices; veterinary clinics range from independent clinics to large clinics with integrated services, while research institutes tend to focus on assay validation and longitudinal studies. Distribution channel segmentation reveals opportunities for direct sales, distributor partnerships, and online procurement, with distributors categorized as national distributors or regional distributors depending on scale and reach. Finally, technology segmentation highlights DNA-based modalities such as LAMP, PCR, and qPCR, immunoassay approaches including agar gel immunodiffusion and ELISA, and microbial culture options across liquid media and solid media platforms.

Synthesizing these segmented dimensions enables targeted product positioning and tailored commercial strategies. For instance, rapid molecular assays map well to diagnostic labs and large clinics with demand for confirmatory testing, while scalable ELISA formats align with high-volume screening needs on dairy farms and breeding operations. Understanding the interplay of animal type, test characteristics, end-user capabilities, distribution channels, and enabling technologies allows stakeholders to prioritize investments and craft differentiated value propositions.

Regional overview of Johne's disease diagnostics spanning Americas, Europe Middle East & Africa, and Asia-Pacific highlighting regulatory, supply, and adoption

Regional context matters because regulatory environments, production systems, and supply chain architectures vary substantially across geographies. In the Americas, diagnostic adoption is influenced by integrated supply chains, large-scale dairy and beef operations, and established laboratory networks, creating opportunities for high-throughput immunoassays and advanced molecular testing that support herd-level surveillance and commercial risk management. By contrast, Europe, Middle East & Africa presents a patchwork of regulatory regimes and veterinary infrastructures where harmonized standards and cross-border collaboration are key to improving access to reliable diagnostics and to supporting regional surveillance initiatives.

Asia-Pacific encompasses diverse production systems, from smallholder operations to intensive commercial farms, and has experienced rapid uptake of point-of-care and molecular testing in response to growing demand for traceability and productivity. Across all three regions, logistical considerations such as cold chain reliability, reagent import pathways, and the geographic distribution of accredited laboratories shape which diagnostic solutions are practical. Moreover, regional differences in regulatory approval timelines, lab accreditation processes, and reimbursement or subsidy frameworks influence the speed at which novel assays become operationally viable.

Taken together, regional insights suggest that successful commercial strategies must align technology deployment with local regulatory expectations, distribution realities, and end-user capabilities. Stakeholders should therefore calibrate product design, service models, and engagement approaches to the specific characteristics of the Americas, Europe Middle East & Africa, and Asia-Pacific markets to maximize uptake and operational impact.

Company-level insights into strategic positioning, partnerships, product portfolios, and R&D focus shaping the Johne's disease diagnostics competitive landscape

Company-level dynamics in Johne's disease diagnostics are shaped by the interplay of product portfolios, strategic partnerships, and an emphasis on validation under real-world conditions. Leading organizations prioritize integrated solutions that combine assay performance with service-level agreements, training, and data management tools. Strategic partnerships between diagnostic manufacturers, distribution networks, and veterinary service providers enable broader market reach while supporting quality assurance and continuity of supply.

Investment in R&D remains central to differentiation, with companies focusing on enhancing sensitivity and specificity, reducing time-to-result, and designing assays that perform robustly across specimen types and stages of infection. Meanwhile, competitive positioning often hinges on the ability to offer scalable options-from high-throughput ELISA platforms suited for herd screening to compact molecular systems designed for decentralized testing. Commercial strategies also reflect an increasing emphasis on lifecycle support, including technical training for end users, structured validation programs, and post-market performance monitoring.

Corporate initiatives that prioritize regulatory alignment, supply chain resilience, and customer-centric service offerings are more likely to achieve sustained adoption. As a result, market leaders are those that integrate technological innovation with pragmatic go-to-market models, enabling veterinary professionals and producers to convert diagnostic information into timely, actionable interventions.

Actionable recommendations for industry leaders to strengthen diagnostics adoption, supply resilience, stakeholder collaboration, and technology choices

Industry leaders can pursue a sequence of pragmatic actions to accelerate the adoption and impact of Johne's disease diagnostics across production systems. First, align product development roadmaps with end-user workflows by co-designing assays and operating protocols with veterinary clinics, diagnostic laboratories, and farm managers to ensure practical fit and user acceptance. Second, strengthen supply chain resilience through diversified sourcing, regional distributor partnerships, and strategic inventory policies that mitigate exposure to trade disruptions and reagent shortages. Third, invest in training and technical support to raise the effective performance of assays in field conditions, reduce user errors, and shorten the learning curve associated with advanced molecular methods.

Additionally, leaders should prioritize data interoperability by adopting standardized reporting formats and laboratory information systems that enable timely data sharing and trend analysis. This enhances surveillance capabilities and supports evidence-based interventions. Collaborations with research institutes can accelerate independent validation and foster real-world evidence generation that underpins broader adoption. Finally, stakeholders should engage proactively with regulatory authorities to streamline approval pathways and to clarify performance expectations for emerging diagnostics. By implementing these recommendations, organizations will improve diagnostic accessibility, enhance the quality of surveillance, and increase the overall efficacy of disease control programs.

Research methodology detailing primary and secondary research approaches, data validation procedures, stakeholder engagement, and analytical frameworks

The research methodology underpinning this executive analysis integrates qualitative and quantitative approaches to ensure rigor and relevance. Primary research comprised structured interviews with laboratory directors, veterinary practitioners, supply chain managers, and research scientists to capture operational realities, validation expectations, and procurement decision criteria. These stakeholder conversations were supplemented by site visits and process observations where feasible, allowing for a grounded appreciation of sampling logistics, throughput constraints, and end-user training needs.

Secondary research involved a systematic review of peer-reviewed literature, technical white papers, and regulatory guidance to triangulate performance claims and to contextualize technological trends. Data validation protocols were implemented to cross-check supplier specifications against independent validation studies and field performance reports. Analytical frameworks employed causal mapping and decision-tree analysis to translate technical attributes into practical implications for different end-user types and regional contexts.

Throughout, transparency in assumptions and a focus on reproducibility guided the research design. Where uncertainty exists, the methodology emphasizes evidence weighting and sensitivity analysis to distinguish well-supported findings from areas requiring further validation. This approach ensures that the insights presented are robust, actionable, and aligned with the needs of decision-makers involved in Johne's disease diagnostics.

Conclusion synthesizing diagnostic advances, operational challenges, and strategic pathways to reduce Johne's disease impact across animal health systems

This conclusion synthesizes the diagnostic advances, operational challenges, and strategic pathways that collectively shape efforts to control Johne's disease. Technological progress in molecular assays and refined immunoassays offers meaningful opportunities to detect infection earlier and to deploy more nuanced herd-level interventions. Yet, operational obstacles-such as supply chain constraints, variable end-user capacity, and regulatory complexity-can impede the translation of diagnostic improvements into measurable reductions in disease impact.

To bridge this gap, coordinated action is necessary: technology providers must align product design with the realities of end-user workflows; distribution networks should pursue resilience and responsiveness; and regulatory stakeholders must collaborate to clarify pathways that incentivize rigorous validation without imposing undue barriers. In parallel, investment in training and data infrastructure will enhance the effective use of diagnostics, enabling stakeholders to convert test results into timely management decisions.

Ultimately, the pathway to sustained improvement rests on the integration of scientific innovation with pragmatic operational planning. By prioritizing interoperability, evidence-based validation, and stakeholder collaboration, the industry can enhance the role of diagnostics in reducing disease burden and in supporting more resilient animal health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Implementation of on-farm rapid PCR assays for Johne's disease early detection in dairy herds
  • 5.2. Integration of next-generation sequencing platforms for comprehensive Johne's disease strain profiling in cattle populations
  • 5.3. Adoption of multiplex ELISA testing platforms to differentiate Johne's disease infections from cross-reactive mycobacteria
  • 5.4. Development of miRNA and protein biomarker panels for preclinical Johne's disease diagnosis and herd management
  • 5.5. Emergence of AI-driven predictive analytics in farm management software to forecast Johne's disease outbreaks
  • 5.6. Increasing regulatory harmonization and validation protocols shaping global Johne's disease diagnostic accuracy requirements
  • 5.7. Growth of subscription-based diagnostic services offering remote sample analysis and real-time Johne's disease monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Johne's Disease Diagnostics Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef Cattle
    • 8.1.2. Dairy Cattle
  • 8.2. Sheep & Goats
    • 8.2.1. Goats
    • 8.2.2. Sheep

9. Johne's Disease Diagnostics Market, by Test Type

  • 9.1. Culture
    • 9.1.1. Liquid Media Culture
    • 9.1.2. Solid Media Culture
  • 9.2. ELISA
    • 9.2.1. Competitive ELISA
    • 9.2.2. Indirect ELISA
    • 9.2.3. Sandwich ELISA
  • 9.3. PCR
    • 9.3.1. Conventional PCR
    • 9.3.2. Real-Time PCR

10. Johne's Disease Diagnostics Market, by End User

  • 10.1. Diagnostic Labs
    • 10.1.1. Hospital Labs
    • 10.1.2. Independent Labs
  • 10.2. Farms
    • 10.2.1. Breeding Farms
    • 10.2.2. Dairy Farms
  • 10.3. Research Institutes
  • 10.4. Veterinary Clinics
    • 10.4.1. Independent Clinics
    • 10.4.2. Large Clinics

11. Johne's Disease Diagnostics Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National Distributors
    • 11.2.2. Regional Distributors
  • 11.3. Online

12. Johne's Disease Diagnostics Market, by Technology

  • 12.1. DNA-Based
    • 12.1.1. LAMP
    • 12.1.2. PCR
    • 12.1.3. qPCR
  • 12.2. Immunoassay
    • 12.2.1. Agar Gel Immunodiffusion
    • 12.2.2. ELISA
  • 12.3. Microbial Culture
    • 12.3.1. Liquid Media
    • 12.3.2. Solid Media

13. Johne's Disease Diagnostics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Johne's Disease Diagnostics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Johne's Disease Diagnostics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. IDEXX Laboratories, Inc.
    • 16.3.2. Zoetis Inc.
    • 16.3.3. Thermo Fisher Scientific Inc.
    • 16.3.4. Neogen Corporation
    • 16.3.5. Abaxis, Inc.
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. Abbott Laboratories, Inc.
    • 16.3.8. QIAGEN N.V.
    • 16.3.9. Biocontrol Systems, LLC
    • 16.3.10. SeQuent Scientific Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. JOHNE'S DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COMPETITIVE ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CONVENTIONAL PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LARGE CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DNA-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LAMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY QPCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY AGAR GEL IMMUNODIFFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIAL CULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET